Table: monthly_update_prescription_drug_wac_inc , manufacturer_name like F*

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  *

oshpd_id manufacturer_name date_reported ndc_number drug_product_description wac_effective_date wac_increase_amount wac_after_increase patent_expiration_date drug_source_type unit_sales_volume_in_us unit_sales_volume_non_public_indicator gross_sales_us_dollars gross_sales_us_dollars_non_public_indicator cost_increase_factors cost_increase_factors_non_public_indicator change_improvement_description change_improvement_non_public_indicator acquisition_date company_acquired_from acquisition_price acquisition_price_non_public_indicator acquisition_price_comment wac_at_acquisition wac_year_prior_to_acquisition year_drug_introduced_to_market wac_at_intro_to_market supporting_documents general_comments
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323069310 Acetylcysteine Solution, USP 10% 100mg/mL 10mL Package Quantity 3 02/19/2025 6.36 51.84 None Non-innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323069130 Acetylcysteine Solution, USP 10% 100mg/mL 30mL Package Quantity 3 02/19/2025 8.73 71.16 None Non-innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323069504 Acetylcysteine Solution, USP 10% 100mg/mL 4mL Package Quantity 25 02/19/2025 44.75 364.00 None Non-innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323069210 Acetylcysteine Solution, USP 20% 200mg/mL 10mL Package Quantity 3 02/19/2025 6.36 51.84 None Non-innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323069030 Acetylcysteine Solution, USP 20% 200mg/mL 30mL Package Quantity 3 02/19/2025 10.92 88.95 None Non-innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323036601 dimenhyDRINATE Injection Solution 50 MG/ML Package Quantity 25 02/19/2025 40.25 328.50 None Non-innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323018410 Folic Acid 50mg 10mL MDV Package Quantity 1 02/19/2025 7.85 63.92 None Non-innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323059613 Glucagon HCl (Diagnostic) Injection Solution Reconstituted 1 MG Package Quantity 10 02/19/2025 310.30 2526.80 None Single Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323051774 Heparin (Porcine) in NaCl Intravenous Solution 25000-0.45 UT/250ML-% Package Quantity 24 02/19/2025 31.92 260.64 None Innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323052277 Heparin Sodium 25,000USP 500mL Freeflex Inj. in 5% Dextrose Package Quantity 24 02/19/2025 34.98 285.60 None Innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323052374 Heparin Sodium 5% Dex 25,000USP 250mL Package Quantity 24 02/19/2025 31.59 257.04 None Innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323034925 Imipenem-Cilastatin Intravenous Solution Reconstituted 250 MG Package Quantity 25 02/19/2025 52.50 427.25 None Non-innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323072510 Remifentanil Hydrochloride for Inj. 5mg 10mL SDV Package Quantity 10 02/19/2025 280.70 3399.60 None Non-innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323046817 Sensorcaine 0.25% 10mL SDV (MPF With Epinephrine) Package Quantity 25 02/19/2025 23.50 191.25 None Non-innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323046417 Sensorcaine 0.25% 10mL SDV (Sterile Pack - MPF) Package Quantity 25 02/19/2025 14.75 178.75 None Non-innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323046417 Sensorcaine 0.25% 10mL SDV (Sterile Pack - MPF) Package Quantity 25 02/19/2025 14.75 178.75 None Non-innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323009330 Sodium Chloride 23.4% 120mEq 30mL SDV Package Quantity 25 02/19/2025 23.50 191.25 None Non-innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323009561 Sodium Chloride 23.4% 400mEq 100mL PBP Package Quantity 20 02/19/2025 43.20 351.40 None Non-innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.
Rx0000129 Fresenius Kabi USA LLC 04/24/2025 63323009020 Sodium Chloride Injection Solution 2.5 MEQ/ML Package Quantity 25 02/19/2025 16.00 129.50 None Non-innovator Multiple Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Price Increase Report is triggered based on 30-day course of therapy.